The changing landscape of heart failure treatment in transthyretin amyloid cardiomyopathy: Is the time ripe for clinical use of sodium-glucose cotransporter 2 inhibitors?
Overview publication
| Title | The changing landscape of heart failure treatment in transthyretin amyloid cardiomyopathy: Is the time ripe for clinical use of sodium-glucose cotransporter 2 inhibitors? |
| Date | 2024-04-01 |
| Issue name | European journal of heart failure |
| Issue number | v26.4:948-951 |
| DOI | 10.1002/ejhf.3245 |
| PubMed | 38623722 |
| Authors | |
| Read | Read publication |